Patients implanted with two iStent injects after cataract surgery experienced reduced IOP and less reliance on medications after 36 months, according to a study.
The prospective, nonrandomized, consecutive case series study included 81 eyes of patients with predominantly primary open-angle glaucoma or pseudoexfoliative glaucoma who underwent cataract surgery and were implanted with two iStent injects (Glaukos). Fifty-six percent of eyes were on three to four medications preoperatively, and one eye was medication-free. Approximately 32% of eyes had previously undergone glaucoma surgery. The
Uncategorized